# Remimazolam Phase II Cardiac Anesthesia Study

> **NCT01937767** · PHASE2 · COMPLETED · sponsor: **Paion UK Ltd.** · enrollment: 90 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol
- **DRUG:** Sevoflurane
- **DRUG:** Remifentanil
- **DRUG:** Fentanyl
- **DRUG:** Rocuronium

## Key facts

- **NCT ID:** NCT01937767
- **Lead sponsor:** Paion UK Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-02-19
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937767, "Remimazolam Phase II Cardiac Anesthesia Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01937767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*